Home/TRIMT/PD Dr. Johannes Notni
PD

PD Dr. Johannes Notni

Managing Partner, Chief Science Officer

TRIMT

Therapeutic Areas

TRIMT Pipeline

DrugIndicationPhase
Trivehexinαvβ6 Integrin-positive CancersPreclinical
Therahexinαvβ6 Integrin-positive CancersPreclinical
Technehexinαvβ6 Integrin-positive CancersPreclinical
Triveoctinαvβ8 Integrin-positive CancersPreclinical
LPDL1PD-L1 positive CancersPreclinical
Undisclosed αvβ6 Integrin Dxαvβ6 Integrin-positive CancersDiscovery